跳至主要内容
临床试验/NCT05193968
NCT05193968招募中不适用

Hot Flashes and Neurovascular Function in Women

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2022年2月24日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
发起方
Mayo Clinic
入组人数
120
试验地点
2
主要终点
Compare microvascular function in women with low and high frequency hot flashes

研究概览

简要总结

Women who experience hot flashes are at greater risk for hypertension and other cardiovascular disease. Neurovascular control mechanisms are likely to play an important role in this relationship. As such, these studies are designed to provide a major step forward in understanding the link between hot flashes and neurovascular dysfunction and, by extension, cardiovascular disease in women.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
40 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Non-smokers.
  • Non-obese.
  • Have at least one ovary.
  • Free from cardiovascular disease.
  • Not taking medications influencing cardiovascular function.

排除标准

  • 未提供

研究组 & 干预措施

Experimental: Healthy Women Volunteers

Other

Hot Flash frequency will be assessed in the study subjects during a screening period. Participants can then chose to participate 1 or 2 study visits- Protocol 1: Microvascular function and/or Protocol 2: Autonomic function

干预措施: Sodium Nitroprusside (Drug)

Experimental: Healthy Women Volunteers

Other

Hot Flash frequency will be assessed in the study subjects during a screening period. Participants can then chose to participate 1 or 2 study visits- Protocol 1: Microvascular function and/or Protocol 2: Autonomic function

干预措施: Acetylcholine (Drug)

Experimental: Healthy Women Volunteers

Other

Hot Flash frequency will be assessed in the study subjects during a screening period. Participants can then chose to participate 1 or 2 study visits- Protocol 1: Microvascular function and/or Protocol 2: Autonomic function

干预措施: Terbutaline (Drug)

Experimental: Healthy Women Volunteers

Other

Hot Flash frequency will be assessed in the study subjects during a screening period. Participants can then chose to participate 1 or 2 study visits- Protocol 1: Microvascular function and/or Protocol 2: Autonomic function

干预措施: Norepinephrine (Drug)

Experimental: Healthy Women Volunteers

Other

Hot Flash frequency will be assessed in the study subjects during a screening period. Participants can then chose to participate 1 or 2 study visits- Protocol 1: Microvascular function and/or Protocol 2: Autonomic function

干预措施: Sympathoexcitatory stressors (Other)

结局指标

主要结局

Compare microvascular function in women with low and high frequency hot flashes

时间窗: Continuous measurement of vascular conductance during infusion of each drug- 3min at baseline and at each drug dose (~60min total of continuous forearm vascular conductance measurements)

Change in forearm vascular conductance with intra-arterial drug infusions. Vascular conductance is an index of vascular tone and is assessed using a technique called venous occlusion plethysmography

Compare sympathetic function in women with low and high frequency hot flashes

时间窗: Continuous measurement of muscle sympathetic nerve activity at rest and in response to stressors (~75min of continuous data collection once a sympathetic nerve signal is found)

Muscle Sympathetic Nerve Activity will be directly using a technique called microneurography.

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sarah E. Baker, Ph.D.

Principal Investigator

Mayo Clinic

研究点 (2)

Loading locations...

相似试验

Hot Flashes and Neurovascular Function in Women | 临床试验